Irina Redchenko

1.4k total citations
20 papers, 919 citations indexed

About

Irina Redchenko is a scholar working on Immunology, Oncology and Genetics. According to data from OpenAlex, Irina Redchenko has authored 20 papers receiving a total of 919 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 11 papers in Oncology and 7 papers in Genetics. Recurrent topics in Irina Redchenko's work include Immunotherapy and Immune Responses (14 papers), Virus-based gene therapy research (7 papers) and Immune Cell Function and Interaction (6 papers). Irina Redchenko is often cited by papers focused on Immunotherapy and Immune Responses (14 papers), Virus-based gene therapy research (7 papers) and Immune Cell Function and Interaction (6 papers). Irina Redchenko collaborates with scholars based in United Kingdom, United States and Russia. Irina Redchenko's co-authors include Alan B. Rickinson, Neil Blake, Miles W. Carroll, Richard Harrop, Susan M. Kingsman, Neil Steven, Elisabeth Bloemena, Ann M. Leen, Pauline Meij and Jaap M. Middeldorp and has published in prestigious journals such as Journal of Clinical Oncology, Immunity and Journal of Virology.

In The Last Decade

Irina Redchenko

19 papers receiving 905 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Irina Redchenko United Kingdom	13	606	599	239	188	158	20	919
J. Joseph Melenhorst United States	18	624 1.0×	348 0.6×	143 0.6×	249 1.3×	163 1.0×	32	1.0k
Franco Marincola United States	14	1.1k 1.7×	627 1.0×	156 0.7×	385 2.0×	96 0.6×	20	1.3k
Hideki Ohminami Japan	15	514 0.8×	412 0.7×	177 0.7×	283 1.5×	90 0.6×	18	920
Michelle A. Neller Australia	18	627 1.0×	490 0.8×	226 0.9×	223 1.2×	72 0.5×	33	992
Lina I. Yoo United States	11	269 0.4×	372 0.6×	294 1.2×	267 1.4×	65 0.4×	15	785
Patrick Squiban France	15	452 0.7×	296 0.5×	126 0.5×	322 1.7×	284 1.8×	33	970
Jean‐Paul Molens France	13	751 1.2×	305 0.5×	119 0.5×	206 1.1×	43 0.3×	20	1.1k
Malcolm K. Brenner United States	13	545 0.9×	902 1.5×	489 2.0×	204 1.1×	312 2.0×	16	1.3k
Marie Roskrow Germany	14	513 0.8×	546 0.9×	174 0.7×	140 0.7×	129 0.8×	24	873
Gianna Ballon United States	12	318 0.5×	462 0.8×	215 0.9×	327 1.7×	55 0.3×	19	954

Countries citing papers authored by Irina Redchenko

Since Specialization

Citations

This map shows the geographic impact of Irina Redchenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irina Redchenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irina Redchenko more than expected).

Fields of papers citing papers by Irina Redchenko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irina Redchenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irina Redchenko. The network helps show where Irina Redchenko may publish in the future.

Co-authorship network of co-authors of Irina Redchenko

This figure shows the co-authorship network connecting the top 25 collaborators of Irina Redchenko. A scholar is included among the top collaborators of Irina Redchenko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irina Redchenko. Irina Redchenko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lozano, Leyder Elena, Sébastien Lofek, Béatris Mastelic-Gavillet, et al.. (2023). Phenotype and Reactivity of Lymphocytes Expanded from Benign Prostate Hyperplasic Tissues and Prostate Cancer. Cancers. 15(12). 3114–3114. 1 indexed citations

Ramirez-Valdez, Ramiro A., Emily Pollock, Federica Cappuccini, et al.. (2021). Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy. Journal for ImmunoTherapy of Cancer. 9(9). e003218–e003218. 16 indexed citations

Hill, Adrian V. S., Mark Tuthill, Federica Cappuccini, et al.. (2021). Abstract IA11: Viral vectored vaccines for prostate cancer. Cancer Immunology Research. 9(2_Supplement). IA11–IA11.

Tuthill, Mark, Federica Cappuccini, Emily Pollock, et al.. (2020). 682P Results from ADVANCE: A phase I/II open-label non-randomised safety and efficacy study of the viral vectored ChAdOx1-MVA 5T4 (VTP-800) vaccine in combination with PD-1 checkpoint blockade in metastatic prostate cancer. Annals of Oncology. 31. S543–S543. 4 indexed citations

Redchenko, Irina, Federica Cappuccini, Emily Pollock, et al.. (2018). VANCE: First-in-human phase I study of a novel ChAdOx1-MVA 5T4 vaccine in low and intermediate risk prostate cancer.. Journal of Clinical Oncology. 36(15_suppl). 3018–3018. 2 indexed citations

Cappuccini, Federica, Emily Pollock, Stephen M. Stribbling, Adrian V. S. Hill, & Irina Redchenko. (2017). 5T4 oncofoetal glycoprotein: an old target for a novel prostate cancer immunotherapy. Oncotarget. 8(29). 47474–47489. 17 indexed citations

Cappuccini, Federica, Stephen M. Stribbling, Emily Pollock, Adrian V. S. Hill, & Irina Redchenko. (2016). Immunogenicity and efficacy of the novel cancer vaccine based on simian adenovirus and MVA vectors alone and in combination with PD-1 mAb in a mouse model of prostate cancer. Cancer Immunology Immunotherapy. 65(6). 701–713. 42 indexed citations

Harrop, Richard, Noel Drury, William Shingler, et al.. (2007). Vaccination of colorectal cancer patients with TroVax given alongside chemotherapy (5-fluorouracil, leukovorin and irinotecan) is safe and induces potent immune responses. Cancer Immunology Immunotherapy. 57(7). 977–986. 63 indexed citations

Harrop, Richard, Noel Drury, William Shingler, et al.. (2007). Vaccination of Colorectal Cancer Patients with Modified Vaccinia Ankara Encoding the Tumor Antigen 5T4 (TroVax) Given Alongside Chemotherapy Induces Potent Immune Responses. Clinical Cancer Research. 13(15). 4487–4494. 73 indexed citations

10.

Redchenko, Irina, Richard Harrop, Matthew G. Ryan, Robert E. Hawkins, & Miles W. Carroll. (2006). Identification of a major histocompatibility complex class I‐restricted T‐cell epitope in the tumour‐associated antigen, 5T4. Immunology. 118(1). 50–57. 16 indexed citations

11.

Harrop, Richard, Irina Redchenko, Juan W. Valle, et al.. (2006). Vaccination of Colorectal Cancer Patients with Modified Vaccinia Ankara Delivering the Tumor Antigen 5T4 (TroVax) Induces Immune Responses which Correlate with Disease Control: A Phase I/II Trial. Clinical Cancer Research. 12(11). 3416–3424. 130 indexed citations

12.

Harrop, Richard, Matthew G. Ryan, Kevin A. Myers, et al.. (2005). Active treatment of murine tumors with a highly attenuated vaccinia virus expressing the tumor associated antigen 5T4 (TroVax) is CD4+ T cell dependent and antibody mediated. Cancer Immunology Immunotherapy. 55(9). 1081–1090. 39 indexed citations

13.

Harrop, Richard, Matthew G. Ryan, Hana Golding, Irina Redchenko, & Miles W. Carroll. (2004). Monitoring of Human Immunological Responses to Vaccinia Virus. Humana Press eBooks. 269. 243–265. 21 indexed citations

14.

Hawkins, Robert D., Richard Harrop, Irina Redchenko, et al.. (2004). Vaccination Against the Tumour Associated Antigen 5T4 Induces Immune Responses in Advanced Colorectal Cancer Patients: Results Phase I/II Clinical Trial with Recombinant Modified Vaccinia Virus Ankara(TroVax). Journal of Immunotherapy. 27(6). S54–S54. 1 indexed citations

15.

Leen, Ann M., Pauline Meij, Irina Redchenko, et al.. (2001). Differential Immunogenicity of Epstein-Barr Virus Latent-Cycle Proteins for Human CD4⁺T-Helper 1 Responses. Journal of Virology. 75(18). 8649–8659. 188 indexed citations

16.

Redchenko, Irina & Alan B. Rickinson. (1999). Accessing Epstein-Barr Virus-Specific T-Cell Memory with Peptide-Loaded Dendritic Cells. Journal of Virology. 73(1). 334–342. 51 indexed citations

17.

Blake, Neil, Irina Redchenko, Wendy Thomas, et al.. (1997). Human CD8 + T Cell Responses to EBV EBNA1: HLA Class I Presentation of the (Gly-Ala)–Containing Protein Requires Exogenous Processing. Immunity. 7(6). 791–802. 222 indexed citations

18.

Гнучев, Н. В., et al.. (1994). Contribution of membrane-associated cytotoxic proteins to cytolysis of L929 and K562 target cells mediated by LAK cells with different phenotypes. Immunology Letters. 39(3). 243–247. 4 indexed citations

19.

Chertov, Oleg, М.В. Ермолаева, Daulet K. Satpaev, et al.. (1994). Inhibitory effect of calf fetuin on the cytotoxic activity of LAK cell-derived factors and tumor necrosis factor. Immunology Letters. 42(1-2). 97–100. 8 indexed citations

20.

Sashchenko, Lidia P., Н. В. Гнучев, Irina Redchenko, et al.. (1993). Time-dependent changes of LAK cell phenotypes correlate with the secretion of different cytotoxic proteins. Immunology Letters. 37(2-3). 153–157. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact